Mario de Angelis

Jul 22, 2024 | urotoday.com | Mario de Angelis

Read the Full Video TranscriptSam Chang: Hello, my name is Sam Chang. I'm a urologist in Nashville, Tennessee at Vanderbilt University Medical Center, and we are privileged to have Professor Mario de Angelis from San Rafael in Milan, Italy, joining us and looking at the impact of radiation and chemotherapy, trimodal therapy or multimodality therapy, for patients with urothelial and non-urothelial invasive bladder cancer.

Feb 16, 2023 | europeanurology.com | Mario de Angelis |Alberto Briganti |Francesco Montorsi |Marco Moschini

• None Maintenance versus non-maintenance intravesical bacillus Calmette-Guerin instillation for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized clinical trials. :• None Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trials. :